![Roberto Díez-Martínez](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Roberto Díez-Martínez
Amministratore Delegato presso Ikan Biotech SL
Profilo
Roberto Díez-Martínez is the founder and Chief Executive Officer of Ikan Biotech SL, a company founded in 2015.
He is currently working as the Chief Operating Officer & Director at Telum Therapeutics SL.
Posizioni attive di Roberto Díez-Martínez
Società | Posizione | Inizio |
---|---|---|
Ikan Biotech SL
![]() Ikan Biotech SL BiotechnologyHealth Technology Ikan Biotech SL engages in the design and development of xenograft models. Its Xenograft Model is a tumour model system to design and test the efficacy of potential drugs for the treatment of cancer. The company was founded by Rubén Díez Punzano and Roberto Díez-Martínez on April 7, 2015 and is headquartered in Noáin, Spain. | Amministratore Delegato | - |
Telum Therapeutics SL
![]() Telum Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Telum Therapeutics SL is a Spanish biotechnology company that specializes in drug discovery and the use of Innovative Phage Lytic Proteins as antibiotics. The company is based in Noáin, Spain. The company has specific programs to treat serious multidrug-resistant Gram-negative infections caused by Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa. Telum Therapeutics leverages the power of nature through the understanding of biological controls exerted by bacteriophages to balance bacterial ecosystems. The CEO of the company is Roberto Díez-Martínez. | Direttore operativo | 19/03/2024 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Ikan Biotech SL
![]() Ikan Biotech SL BiotechnologyHealth Technology Ikan Biotech SL engages in the design and development of xenograft models. Its Xenograft Model is a tumour model system to design and test the efficacy of potential drugs for the treatment of cancer. The company was founded by Rubén Díez Punzano and Roberto Díez-Martínez on April 7, 2015 and is headquartered in Noáin, Spain. | Health Technology |
Telum Therapeutics SL
![]() Telum Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Telum Therapeutics SL is a Spanish biotechnology company that specializes in drug discovery and the use of Innovative Phage Lytic Proteins as antibiotics. The company is based in Noáin, Spain. The company has specific programs to treat serious multidrug-resistant Gram-negative infections caused by Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa. Telum Therapeutics leverages the power of nature through the understanding of biological controls exerted by bacteriophages to balance bacterial ecosystems. The CEO of the company is Roberto Díez-Martínez. | Commercial Services |
- Borsa valori
- Insiders
- Roberto Díez-Martínez